RUBCN
RUBCN (rubicon autophagy regulator, also known as rubicon, rundataxin and KIAA0226) is a negative regulator of autophagy and endocytic trafficking that controls endosome maturation. It also shapes host defence responses in activated macrophages. Browse Assay Genie's current range of RUBCN research reagents below, or read on for the biology behind the target.
RUBCN acts as a negative regulator of autophagy and endocytic trafficking, and it controls endosome maturation. In innate immunity, it contributes to pathogen-specific host defence in activated macrophages. After bacterial infection, RUBCN promotes NADH oxidase activity by associating with CYBA, which affects TLR2 signalling and probably other TLR-NOX pathways. It stabilises the CYBA:CYBB NADPH oxidase heterodimer and increases its association with TLR2 and its phagosome trafficking. This drives the antimicrobial burst of reactive oxygen species and the production of inflammatory cytokines.
RUBCN also has a restraining role. After fungal or viral infection, involving CLEC7A (dectin-1)-mediated myeloid cell activation or RIGI-dependent sensing of RNA viruses, it negatively regulates pro-inflammatory cytokine production. It does this by associating with CARD9 and sequestering it from signalling complexes. The protein is found at late endosomes, lysosomes and early endosomes.
The RUBCN gene encodes a protein with an N-terminal RUN domain, which is involved in Ras-like GTPase signalling, and a C-terminal DUF4206 domain that contains a diacylglycerol (DAG) binding-like motif. HGNC places it in the PIK3C3 complex subunits, RUN domain containing, and microRNA protein coding host gene groups. A mutation that deletes the DAG binding-like motif causes a recessive ataxia, which fits the alias rundataxin. The previous symbol KIAA0226 is still seen in older literature. Alternatively spliced transcript variants encode distinct isoforms. The mouse ortholog is Rubcn.
RUBCN is a negative regulator of autophagy, making it a key target for studying how autophagic activity is restrained.
RUBCN controls endosome maturation and endocytic trafficking, and it localises to early and late endosomes and lysosomes.
RUBCN stabilises the CYBA:CYBB NADPH oxidase and affects TLR2 signalling, linking it to the antimicrobial ROS burst and cytokine production.
Loss of the DAG binding-like motif of RUBCN causes a recessive ataxia, so the protein is relevant to studies of inherited neurological disorders.
RUBCN negatively regulates autophagy and endocytic trafficking and controls endosome maturation. In macrophages it stabilises the CYBA:CYBB NADPH oxidase to support the antimicrobial ROS burst, and it restrains pro-inflammatory cytokine production after fungal or viral infection by sequestering CARD9.
RUBCN stands for rubicon autophagy regulator. It is also called rubicon, rundataxin and KIAA0226. The previous HGNC name was RUN and cysteine rich domain containing beclin 1 interacting protein. UniProt lists it as Run domain Beclin-1-interacting and cysteine-rich domain-containing protein. Alternative splicing produces distinct isoforms.
A mutation in the RUBCN gene that deletes the DAG binding-like motif causes a recessive ataxia. The mouse ortholog is Rubcn. Check the datasheet of any product for its validated reactivity.
Autophagy regulators, NADPH oxidase components and innate immune signalling partners of RUBCN with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92622; product specifications from Assay Genie datasheets.